Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Recursion Pharmaceuticals Inc Cl A
(NQ:
RXRX
)
6.940
+0.390 (+5.95%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Oct 18, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
3,633,881
Open
6.570
Bid (Size)
6.920 (1)
Ask (Size)
6.940 (8)
Prev. Close
6.550
Today's Range
6.570 - 6.950
52wk Range
4.970 - 15.74
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Prediction: These 2 Stocks Could Soar in 2025
October 17, 2024
The key word here is "could."
Via
The Motley Fool
Cathie Wood Is Betting on This AI Stock: Is It a Buy?
October 15, 2024
Wood has a stake in this stock, but it's hardly an "all-in" bet.
Via
The Motley Fool
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Performance
YTD
-29.69%
-29.69%
1 Month
+2.06%
+2.06%
3 Month
-14.74%
-14.74%
6 Month
-8.68%
-8.68%
1 Year
+21.75%
+21.75%
More News
Read More
Down 57% in 2024, Is Recursion Pharmaceuticals a Buy on the Dip?
October 15, 2024
Via
The Motley Fool
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
October 08, 2024
Via
The Motley Fool
2 Artificial Intelligence Stocks That Could Deliver Explosive Gains
October 07, 2024
Via
The Motley Fool
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Is Recursion Pharmaceuticals Stock a Buy?
September 20, 2024
Via
The Motley Fool
Looking Into Recursion Pharmaceuticals's Recent Short Interest
September 16, 2024
Via
Benzinga
Decoding 6 Analyst Evaluations For Recursion Pharmaceuticals
September 04, 2024
Via
Benzinga
How Is The Market Feeling About Recursion Pharmaceuticals?
August 23, 2024
Via
Benzinga
Recursion Announces FDA Clearance of Investigational New Drug Application for REC-1245, a Potential First-In-Class RBM39 Degrader for Biomarker-Enriched Solid Tumors and Lymphoma
October 02, 2024
From
Recursion Pharmaceuticals, Inc.
Via
GlobeNewswire
2 Innovative Cathie Wood Stocks to Buy If You Can Stomach the Risk
September 29, 2024
Via
The Motley Fool
AI-Focused Drug Discovery Stocks +6% Last Week Vs. -8% Previous Week
September 15, 2024
Via
Talk Markets
AI-Focused Drug Discovery Stocks Portfolio -8% W/e Sept 6th
September 10, 2024
Via
Talk Markets
These AI-Related Stocks Were Down +10% Week Ending September 6
September 07, 2024
Via
Talk Markets
Topics
Economy
Exposures
Economy
Interest Rates
Our AI-Focused Drug Discovery Stocks Portfolio Down 8% In August; Down 6.7% Yesterday Alone!
September 05, 2024
Via
Talk Markets
Topics
Economy
Exposures
Economy
Crude Oil Dips Over 4%; SPAR Group Shares Spike Higher
September 03, 2024
Via
Benzinga
Exposures
Fossil Fuels
Nasdaq Dips Over 2%; US Construction Spending Falls In July
September 03, 2024
Via
Benzinga
Recursion Pharmaceuticals Stock Is Sliding Tuesday: What's Going On?
September 03, 2024
Via
Benzinga
Why Recursion Pharmaceuticals Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
September 03, 2024
Via
Benzinga
Recursion Announces Phase 2 Data of REC-994, a First-in-Disease Investigational Treatment for Symptomatic Cerebral Cavernous Malformation (CCM), has Met its Primary Endpoint of Safety and Tolerability
September 03, 2024
From
Recursion Pharmaceuticals, Inc.
Via
GlobeNewswire
Is Recursion Pharmaceuticals a Warren Buffett Stock?
August 30, 2024
Via
The Motley Fool
Our AI-Focused Drug Discovery Stocks Portfolio Was Up Almost 7% Last Week
August 27, 2024
Via
Talk Markets
The Bull Thesis for Recursion Pharmaceuticals Stock Just Got Stronger. Here's Why.
August 18, 2024
Via
The Motley Fool
Is Recursion Pharmaceuticals Stock a Buy?
August 17, 2024
Via
The Motley Fool
AI-Focused Drug Discovery Stocks Portfolio Hit Hard: Down 14% MTD
August 14, 2024
Via
Talk Markets
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.